TY - JOUR
T1 - Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting
AU - Perani, Daniela
AU - Della Rosa, Pasquale Anthony
AU - Cerami, Chiara
AU - Gallivanone, Francesca
AU - Fallanca, Federico
AU - Vanoli, Emilia Giovanna
AU - Panzacchi, Andrea
AU - Nobili, Flavio
AU - Pappatà, Sabina
AU - Marcone, Alessandra
AU - Garibotto, Valentina
AU - Castiglioni, Isabella
AU - Magnani, Giuseppe
AU - Cappa, Stefano F.
AU - Gianolli, Luigi
AU - Drzezga, Alexander
AU - Perneczky, Robert
AU - Didic, Mira
AU - Guedj, Eric
AU - Van Berckel, Bart N.
AU - Ossenkoppele, Rik
AU - Morbelli, Silvia
AU - Frisoni, Giovanni
AU - Caroli, Anna
AU - EADC-PET Consortium
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Diagnostic accuracy in FDG-PET imaging highly depends on the operating procedures. In this clinical study on dementia, we compared the diagnostic accuracy at a single-subject level of a) Clinical Scenarios, b) Standard FDG Images and c) Statistical Parametrical (SPM) Maps generated via a new optimized SPM procedure. We evaluated the added value of FDG-PET, either Standard FDG Images or SPM Maps, to Clinical Scenarios. In 88 patients with neurodegenerative diseases (Alzheimer's Disease-AD, Frontotemporal Lobar Degeneration-FTLD, Dementia with Lewy bodies-DLB and Mild Cognitive Impairment-MCI), 9 neuroimaging experts made a forced diagnostic decision on the basis of the evaluation of the three types of information. There was also the possibility of a decision of normality on the FDG-PET images. The clinical diagnosis confirmed at a long-term follow-up was used as the gold standard. SPM Maps showed higher sensitivity and specificity (96% and 84%), and better diagnostic positive (6.8) and negative (0.05) likelihood ratios compared to Clinical Scenarios and Standard FDG Images. SPM Maps increased diagnostic accuracy for differential diagnosis (AD vs. FTD; beta 1.414, p = 0.019). The AUC of the ROC curve was 0.67 for SPM Maps, 0.57 for Clinical Scenarios and 0.50 for Standard FDG Images. In the MCI group, SPM Maps showed the highest predictive prognostic value (mean LOC = 2.46), by identifying either normal brain metabolism (exclusionary role) or hypometabolic patterns typical of different neurodegenerative conditions.
AB - Diagnostic accuracy in FDG-PET imaging highly depends on the operating procedures. In this clinical study on dementia, we compared the diagnostic accuracy at a single-subject level of a) Clinical Scenarios, b) Standard FDG Images and c) Statistical Parametrical (SPM) Maps generated via a new optimized SPM procedure. We evaluated the added value of FDG-PET, either Standard FDG Images or SPM Maps, to Clinical Scenarios. In 88 patients with neurodegenerative diseases (Alzheimer's Disease-AD, Frontotemporal Lobar Degeneration-FTLD, Dementia with Lewy bodies-DLB and Mild Cognitive Impairment-MCI), 9 neuroimaging experts made a forced diagnostic decision on the basis of the evaluation of the three types of information. There was also the possibility of a decision of normality on the FDG-PET images. The clinical diagnosis confirmed at a long-term follow-up was used as the gold standard. SPM Maps showed higher sensitivity and specificity (96% and 84%), and better diagnostic positive (6.8) and negative (0.05) likelihood ratios compared to Clinical Scenarios and Standard FDG Images. SPM Maps increased diagnostic accuracy for differential diagnosis (AD vs. FTD; beta 1.414, p = 0.019). The AUC of the ROC curve was 0.67 for SPM Maps, 0.57 for Clinical Scenarios and 0.50 for Standard FDG Images. In the MCI group, SPM Maps showed the highest predictive prognostic value (mean LOC = 2.46), by identifying either normal brain metabolism (exclusionary role) or hypometabolic patterns typical of different neurodegenerative conditions.
KW - Dementia diagnosis
KW - FDG-PET imaging
KW - Statistical parametrical mapping
KW - Voxel-based analysis
UR - http://www.scopus.com/inward/record.url?scp=84910087093&partnerID=8YFLogxK
U2 - 10.1016/j.nicl.2014.10.009
DO - 10.1016/j.nicl.2014.10.009
M3 - Article
C2 - 25389519
AN - SCOPUS:84910087093
VL - 6
SP - 445
EP - 454
JO - NeuroImage: Clinical
JF - NeuroImage: Clinical
SN - 2213-1582
ER -